China is fuelling fears of a ‘more dangerous’ Cold War. Here’s how it could unfold

Rising rhetoric from President Trump about restarting nuclear testing and advancing a 'Golden Dome' missile‑defense program, coupled with a thinly staffed arms‑control apparatus, is raising concerns among experts that the U.S., China and Russia could enter an unstable arms‑race dynamic. Markets should watch increased geopolitical risk and policy uncertainty—potentially supportive for defense contractors and risk premia—while arms‑control breakdown would elevate volatility and strategic uncertainty for global asset allocations.

Analysis

Market structure: A renewed US-China-Russia arms dynamic would directly benefit large defense primes (NOC, LMT, RTX, GD) and upstream suppliers (semiconductors for guided systems, rare earth/mining). Expect pricing power in classified/sole-source contracts and multi-year backlog growth; lead times for critical subsystems could extend 6–18 months, tightening supply and supporting margin expansion. Conversely, consumer discretionary, international travel, and China-exposed tech vendors would see demand erosion and higher risk premia.

Risk assessment: Tail risks include an actual restart of nuclear testing or an exchange of punitive measures that could trigger a >10% broad equity drawdown and safe-haven flows into Treasuries/gold; probability low (<10%) but impact severe. Short-term (days–weeks) is headline-driven volatility; medium-term (3–12 months) depends on FY defense budgets and Congressional appropriation cycles; long-term (years) on industrial base rebuild and export-control regimes. Hidden dependencies: Congress funding, supply-chain chokepoints (ASIC fabs, rare earths), and program execution risk.

Trade implications: Tactical long exposure to diversified primes (NOC/LMT) and commodity plays (uranium miners/URA) is justified; buy 3–9 month call spreads to cap cost and take advantage of volatile policy windows. Rotate into Treasuries (2–5y) and USD on risk-off spikes (implement when VIX >25 or S&P500 down >5% in 3 days). Use pair trades (long NOC vs short airlines/PLBY) to express defense outperformance vs cyclical travel/leisure.

Contrarian angles: The market may overprice immediate escalation — many missile-defense projects fail or delay; prefer firms with broad backlog and cash flow over single-program bets. Look for buying opportunities on 5–10% pullbacks in primes rather than chasing headlines; monitor three catalytic data points in the next 30–90 days: White House budget release, Congressional markups, and any announced test by China/Russia as triggers to scale exposure.

Key Decisions for Investors

• Establish a 2–3% portfolio long position split 60/40 NOC (Northrop Grumman) / LMT (Lockheed Martin) over next 2–8 weeks; add another 1% if Pentagon budget proposals show >5% YoY defence spending increase or either stock falls 5–10%.
• Buy 3–9 month call spreads on NOC and LMT (size 0.5% portfolio each): buy 1 5% OTM call and sell 1 15% OTM to limit premium; roll or close on a 25–40% paper gain or if contract awards/delivery schedules are delayed beyond 6 months.
• Allocate 1–2% to uranium exposure (CCJ or URA ETF); add another 1% if spot U3O8 rises >15% or if policy announces accelerated testing/enrichment; take profits/trim at +40% realized gain.
• Cut discretionary leisure/consumer exposure: reduce PLBY and similar China/exposure leisure names by 50% within 1–2 weeks and redeploy proceeds into NOC/LMT or 2–5y Treasuries (or TLT) when VIX >25 or S&P500 declines >5% over 3 trading days.
• Implement a relative-value pair: long NOC (1.5% portfolio) vs short UAL (1.5%) for 3–6 months to capture defense vs travel divergence; unwind if NOC outperforms UAL by >15% or travel metrics (airline traffic pax) recover to pre-COVID trend for two consecutive months.